(Date:12/7/2009)... Chicago have discovered a technique that is able to ... or habitual snoring by screening their urine. , ... relatively simple urine test that could detect OSA in ... and inconvenient sleep studies in children who snore, only ... OSA," said lead author David Gozal, M.D., professor and ...
(Date:12/6/2009)... and SUNNYVALE, Calif., Dec. 6 Pharmacyclics, ... results from a Phase I/II study showing safety ... recurrent non-Hodgkin,s Lymphoma (NHL) treated with its HDAC ... were presented today at the 51st ASH Annual ... # 2726). ,, PCI-24781 is an oral ...
(Date:12/6/2009)... Scientists in Cambridge have discovered that the loss of a ... This is the first study to show that this kind ... today in Nature . , The study, led by ... Matt Hurles from the Wellcome Trust Sanger Institute, looked at ... child,s entire genome looking for types of mutation known as ...
(Date:12/6/2009)... researchers from the Medical College of Wisconsin, in Milwaukee, ... and other sickle cell disease complications in children. Barriers ... and patients were also identified. The study led ... pediatrics at the Medical College and Children,s Research Institute ... at the American Society of Hematology meeting Dec. 7, ...
(Date:12/6/2009)... -- Blood clotting, or coagulation, is an important ... vessel is injured. Sometimes, however, clots form on ... or do not dissolve naturally, a potentially life-threatening ... 51st Annual Meeting of the American Society of ... anticoagulants aspirin and heparin with the hope of ...
Breaking Medicine News(10 mins):Health News:Urine test for pediatric obstructive sleep apnea possible 2Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 2Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 3Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 4Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 5Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7... SHENZHEN, China, Feb. 14 /Xinhua-PRNewswire-FirstCall/ -- China Display,Technologies, ... "the,Company"), a leading manufacturer of optoelectronic products, specializing,in ... for LCD displays in,China, today announced its Vice ... Officer, Mr. Kam Ming Yip will present at ...
... of genes that prevent cell death in those with ... Researchers from Saint Louis University report that a pile-up ... finding which could point to new therapies for the ... finding new treatments for lupus," said Dr. Jill Buyon, ...
... nomination campaign, some candidates health care plans have been ... has been used to attack health reform proposals in ... Opinion Research Program at the Harvard School of Public ... split on whether a socialized medical system would be ...
... 14 Workplace stress is the,most frequently cited ... acknowledge that stress is affecting business performance,few are ... surveys by Watson,Wyatt Worldwide, a leading global consulting ... percent) say stress caused by working,long hours is ...
... Officials at,Southern Research Institute today announced that Wilson ... has been named Vice,President of its Drug Discovery ... "We are very pleased that Dr. Knight has ... research program," said John A. "Jack" Secrist,III, Ph.D., ...
... WASHINGTON, Feb. 14 Lung Cancer Alliance,announced today ... joined its Board of Directors., LCA Board ... the,following statement:, "Secretary Mineta,s remarkable career in ... leadership on national security, transportation,infrastructure and technology issues ...
Other Medicine News:Health News:China Display Technologies, Inc. to Present at Roth Conference 2Health News:China Display Technologies, Inc. to Present at Roth Conference 3Health News:Overabundance of Immune Cells Might Trigger Lupus 2Health News:Overabundance of Immune Cells Might Trigger Lupus 3Health News:Poll finds Americans split by political party over views on socialized medicine 2Health News:Poll finds Americans split by political party over views on socialized medicine 3Health News:Few Employers Addressing Workplace Stress, Watson Wyatt Surveys Find 2Health News:Few Employers Addressing Workplace Stress, Watson Wyatt Surveys Find 3Health News:Southern Research Institute Names Blaine Knight Vice President of Drug Discovery 2Health News:Secretary Norman Y. Mineta Joins Lung Cancer Alliance Board of Directors 2(Date:12/4/2009)... Imaging, LLC, an independent provider of CT, MRI ... and healthcare providers, is excited to announce it ... Health Care, a nationally-recognized, prestigious gold seal of ... Shared Imaging accreditation is system-wide for its mobile ...
(Date:12/4/2009)... Ill., Dec. 4 Hospira, Inc. (NYSE: ... delivery company, today announced the launch of its next-generation ... (I.V.) medications and solutions, and now offers a complete ... award-winning, environmentally responsible VisIV product. The launch of the ...
(Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, today ... and Chief Financial Officer. In this role, Mr. ... functions including finance, accounting, IT, IR, administration and human ... senior management team. ,, "One of my key ...
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Toms of Maine Invites Public Participation in 50 States for Good Program 48207 1Toms of Maine Invites Public Participation in 50 States for Good Program 48207 2More Ontario children are getting diagnosed with diabetes 3A ICES study 48205 1Common chemotherapy drug triggers fatal allergic reactions 8748 1Common chemotherapy drug triggers fatal allergic reactions 8748 2Common chemotherapy drug triggers fatal allergic reactions 8748 3... Met - Up to 88% Efficacy, SEOUL, Korea, ... announced today that it has completed a 340 ... new long acting (12,hour half-life) oral phosphodiesterase type ... study conducted in the,U.S. was a randomized, double-blind, ...
... the year ended 31 December 2006 , Product ... Phase,III study International partnering process to commerialise M6G,underway ... Pharmaceuticals,plc ("CeNeS" or "the Company"), the CNS focused ... the year ended 31 December 2006. , Operational ...
Other Medicine Technology:Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil,Its New Long Acting Drug For Erectile Dysfunction 2Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil,Its New Long Acting Drug For Erectile Dysfunction 3Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil,Its New Long Acting Drug For Erectile Dysfunction 4CeNeS Pharmaceuticals Plc Announces Preliminary Results for The,Year Ending 31 December 2006 2CeNeS Pharmaceuticals Plc Announces Preliminary Results for The,Year Ending 31 December 2006 3... The Acclaim 7000 Nd:YAG laser ... by offering cosmetic procedures such as ... facial veins, our Dermique LaserFACIAL for ... offers selectable parameters for customizing treatment ...
... laser beam is delivered through an ultra thin ... the operator full freedom of movement when performing ... with a wide range of handpieces. Handpieces ... mm and 16 mm. Straight and angled ...
VERSASTEP™ Reposable Reusable Components (Standard Length)....
VERSASTEP™ Reposable Single Use Trocar For use with VERSASTEP™ Reusable Cannula, Dilator....
Medicine Products: